News | Coronavirus (COVID-19) | July 28, 2020

ams Accelerates Supply of CT Detector Technology

ams Commended by United Imaging for Accelerated Supply of Unprecedented Levels of Essential CT Detectors to Fight Covid-19 (SARS-CoV-2)

ams Commended by United Imaging for Accelerated Supply of Unprecedented Levels of Essential CT Detectors to Fight Covid-19 (SARS-CoV-2)

July 28, 2020 — ams, a leading worldwide supplier of high performance sensor solutions, has been thanked by long-term customer, United Imaging, for its outstanding contribution to helping hospitals in China to diagnose respiratory complications of some of the first Covid-19 (SARS-CoV-2) patients. United Imaging’s computed tomography (CT) scanners were needed quickly by hospitals in China and increasingly around the world. At this time of continuing medical crisis in a number of countries, ams is delivering its industry-leading CT detector technology to United Imaging. Both companies together demonstrated their corporate social responsibility by supporting CT examination in frontline hospitals to fight the threat of Covid-19 (SARS-CoV-2) to China and the world.

United Imaging develops and produces advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging, diagnosis and treatment. Founded in 2011 with global headquarters in Shanghai, the company has subsidiaries and R&D centers across China and around the world. On January 27, the company sent an emergency notification letter to suppliers: ams immediately responded to resume work and production, overcoming numerous logistical difficulties to supply sensor components to United Imaging with urgently needed CT and digital radiology equipment for use by medical teams on the front line of the Covid-19 (SARS-CoV-2) outbreak.

An official letter of appreciation from Lv Yun-Lei, VP Procurement of United Imaging said: “As a leading enterprise in China’s high-end medical equipment industry, United Imaging’s medical equipment has been widely used in hospitals across the country, including Huoshenshan Hospital, Leishenshan Hospital, and mobile hospitals in Wuhan, making outstanding contributions to fighting the epidemic, and winning high praise from the governments, hospitals, and people in the affected areas. It is ams’ strong sense of social responsibility, together with United Imaging and the people of the whole country, that caused a turning point in this war without gunfire.”

With the epidemic in China effectively controlled, the country is now facing huge demand to fulfill foreign exports. United Imaging is no exception, with customers in several countries requesting medical supplies to deal with their own outbreaks of the virus. This has resulted in an unprecedented demand for the fast delivery of United Imaging equipment not only domestically, but internationally. To achieve this, United Imaging states that it intends to work jointly with ams to make greater contributions to healthcare in China and worldwide.

Pinglu Chen, Senior Vice President Greater China, ams, responded: “This is a great example of fulfilling our vision of delivering technology innovation for a better lifestyle. Like United Imaging, I firmly believe that with the efforts of governments and the people of all countries, we will be able to control Covid-19 (SARS-CoV-2). On behalf of the whole team at ams, I am proud to have made this and other contributions to detecting and addressing this deadly virus, and in doing so improving medical outcomes for people around the world.”

Computed Tomography (CT)

Medical professionals are constantly pushing CT imaging equipment manufacturers to provide higher resolution images, which allow for more accurate diagnosis of a patient’s condition, while at the same time keeping X-ray dosage to a minimum, to reduce the risk to the patient’s health when undergoing a scan.

New generations of detector solutions from ams are helping equipment makers to achieve both these goals, giving reductions in X-ray doses while producing motion-free CT images.

The reason for the ams detectors’ superior performance is that they reduce noise in the sensitive analog signal chain between the photodiode and the high-speed ADC. ams technologies also eliminate the dead time that is required in the operation of many ADCs, maximizing the linearity of the output.

For more information: https://ams.com/medical-health

Related Content

Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health S

Kaplan-Meier curves for all-cause mortality in patients with versus without myocardial injury (Panel A) and in patients with versus without myocardial injury according to the presence or absence of major echocardiographic abnormalities (Panel B). *Includes wall motion abnormalities, global left ventricular dysfunction, diastolic dysfunction, right ventricular dysfunction and presence of pericardial effusion. Event rates are censored at 20 days from hospital admission. Images courtesy of Mount Sinai Health System

News | Ultrasound Imaging | October 28, 2020
October 28, 2020 — Card...
Ceiling-mounted X-ray system includes MyExam Companion intelligent user interface to guide technologist through exam workflow
News | X-Ray | October 26, 2020
October 26, 2020 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the...
AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

Feature | CT Angiography (CTA) | October 23, 2020
October 22, 2020 – In the FORECAST randomized clinical trial, the use of ...
This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large

This illustration show the complexity of the data obtained from one single patient with moderate/severe traumatic brain injury. Different imaging approaches and techniques have their own unique sensitivity in assessing different aspects of neuroanatomy and neuropathology. What can be seen on images also changes with time since injury. Data from comprehensive clinical and functional assessments using a range of other tools is also important for evaluating patient outcome. Through data harmonization and large-scale analyses of data combined across multiple research sites, the ENIGMA Brain Injury will develop and test methods and procedures for making sense of the complexity in this data. Images courtesy of Olsen et al., Brain Imaging and Behavior, 2020

News | Magnetic Resonance Imaging (MRI) | October 23, 2020
October 23, 2020 — Trau...
A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe.

A, Initial conventional axial CT image shows no noticeable lung damage (within red box) in right upper lobe. B, Electron density spectral CT image obtained at same time as image in A shows lesions (within red box) in right upper lobe. C, Follow-up conventional axial chest CT image obtained 5 days after images in A and B confirm presence of lesions (within red box) in right upper lobe. Image courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | October 22, 2020
October 22, 2020 — According to an open-...
The fMRI hyperscanning environment.

(A) The fMRI hyperscanning environment. The clinician (1) and patient (2) were positioned in two different 3T MRI scanners. An audio-video link enabled online communication between the two scanners (3), and video images were used to extract frame-by-frame facial expression metrics. During simultaneous acquisition of blood oxygen level–dependent (BOLD)–fMRI data, the clinician used a button box (4) to apply electroacupuncture (EA) treatment (real/sham, double-blind) to the patient (5) to alleviate evoked pressure pain to the leg (6; Hokanson cuff inflation). Pain and affect related to the treatment were rated after each trial. (B) Study overview. After an initial behavioral visit, each individual participated in a Clinical-Interaction (hyperscan preceded by a clinical intake) and No-Interaction condition (hyperscan without a preceding intake), in a counterbalanced order, with two different partners. (C) Experimental protocol. Each hyperscan was composed of 12 repeated trials (four verum EA, four sham EA, and four no treatment) in a pseudo-randomized order. After a resting period (far left), both participants were shown a visual cue to indicate whether the next pain stimulus would be treated (green frame) or not treated (red frame) by the clinician. These cues prompted clinicians prepare to either apply or not apply treatment while evoking corresponding anticipation for the patient. Following the anticipation cue, moderately painful pressure pain was applied to the patient’s left leg, while the clinician applied or did not apply treatment, respectively. After another resting period, participants rated pain (patients), vicarious pain (clinicians), and affect (both) using a visual analog scale (VAS).

News | Clinical Trials | October 22, 2020
October 22, 2020 — The potential impact of the patient-clinician relationship on a patient's response to treatment is
Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA)

Lesion was originally reported as indeterminate enhancing mass, and outside report recommended biopsy. Classic features of benign hemangioma are shown. Error was attributed to faulty reasoning. A, Axial MR image obtained 5 minutes after contrast agent administration shows peripheral nodular discontinuous enhancement. B, Axial MR image obtained 10 minutes after contrast agent administration shows centripetal progression of enhancement (arrow). C, Axial fast imaging employing steady-state acquisition (FIESTA) MR image shows lesion is homogeneously hyperintense compared with liver parenchyma. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | October 21, 2020
October 21, 2020 — According to an artic...
According to an inquest, a man with a heart disorder and chest pain died two days after a doctor viewed the wrong scan and sent him home
News | Computed Tomography (CT) | October 21, 2020
October 21, 2020 — The BBC News